2,8-Dihydroxyadenine-induced nephropathy causes hexosylceramide accumulation with increased mTOR signaling, reduced levels of protective SirT3 expression and impaired renal mitochondrial function-Reference-Cited by-同舟云学术

2,8-Dihydroxyadenine-induced nephropathy causes hexosylceramide accumulation with increased mTOR signaling, reduced levels of protective SirT3 expression and impaired renal mitochondrial function

Published:2024-01 Issue:1 Volume:1870 Page:166825
ISSN:0925-4439
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Author:

Moellmann Julia,Krueger Katja,Wong Dickson W.L.,Klinkhammer Barbara M.,Buhl Eva M.,Dehairs Jonas,Swinnen Johan V.,Noels Heidi,Jankowski Joachim,Lebherz Corinna,Boor Peter,Marx Nikolaus,Lehrke Michael

Publisher

Elsevier BV

Subject

Molecular Biology,Molecular Medicine

Reference54 articles.

1. Accelerated vascular aging in chronic kidney disease: the potential for novel therapies;Hobson;Circ. Res.,2023

2. How many cell types are in the kidney and what do they do?;Balzer;Annu. Rev. Physiol.,2022

3. Uraemic cardiomyopathy: a review of current literature;Garikapati;Clin Med Insights Cardiol,2021

4. Secular trends in cardiovascular mortality rates of patients receiving dialysis compared with the general population;Roberts;Am. J. Kidney Dis.,2011

5. Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options;Jankowski;Circulation,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of mitochondria in reno-cardiac diseases: A study of bioenergetics, biogenesis, and GSH signaling in disease transition;Redox Biology;2024-10

2. SLC25A48 controls mitochondrial choline import and metabolism;Cell Metabolism;2024-09

3. Metabolomic and Physiological Effects of a Cardiorenal Protective Diet Intervention in African American Adults with Chronic Kidney Disease;Metabolites;2024-05-25

4. Discovery of 2,8-dihydroxyadenine in HUA patients with uroliths and biomarkers for its associated nephropathy;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-04